Encephalopathy Due to COVID-19 With Great Response to Glucocorticoids
Open Access
- 9 September 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cureus
- Vol. 13 (9)
- https://doi.org/10.7759/cureus.17845
Abstract
Minor neurological symptoms such as anosmia are relatively common manifestations of coronavirus disease 2019 (COVID-19). However, severe affection of the central nervous system (CNS) occurs in a minority of cases and its treatment and pathophysiology is not yet well understood. It has been described that encephalitis due to COVID-19 may be caused by the proinflammatory state due to the cytokine storm or direct invasion of the virus in the CNS. Here we present a case of a 66-year-old man with bipolar disorder and moderate respiratory COVID-19 symptoms who presented to the emergency department with a decreased level of consciousness. Brain computerized tomography (CT) showed no acute pathology. A thorough investigation of other possible causes of CNS affection was negative. The patient was treated with pulse therapy with methylprednisolone and presented a significant improvement of his neurological condition, being discharged with a complete neurological recovery five days after the start of the treatment. This case illustrates the importance of a high index of suspicion in diagnosing severe CNS impairment in mild respiratory COVID-19 cases. Also, this case corroborates with previous reports of glucocorticoid response in CNS impairment associated with COVID-19, although more robust studies are required to confirm this relation.This publication has 10 references indexed in Scilit:
- “Neurological manifestations of COVID-19” - guideline of the German society of neurologyNeurological Research and Practice, 2020
- Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patientsAnnals of Clinical and Translational Neurology, 2020
- Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2–Related Encephalitis: The ENCOVID Multicenter StudyThe Journal of Infectious Diseases, 2020
- COVID-19–related encephalopathy responsive to high-dose glucocorticoidsNeurology, 2020
- Lifting the mask on neurological manifestations of COVID-19Nature Reviews Neurology, 2020
- Neurological associations of COVID-19The Lancet Neurology, 2020
- Encephalopathy in patients with COVID‐19: A reviewJournal of Medical Virology, 2020
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, ChinaJAMA Neurology, 2020
- Steroid‐Responsive Encephalitis in Coronavirus Disease 2019Annals of Neurology, 2020
- A medical overview of encephalitisNeuropsychological Rehabilitation, 2007